Surgical Oncology
Volume 19, Issue 2 , Pages 82-87 , June 2010

Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma

  • Miao Ouyang

      Affiliations

    • Department of Gastroenterology, Xiangya hospital, Central South University, Changsha, Hunan 410008, China
    • ,
  • Wei Wu

      Affiliations

    • Department of Surgery, Xiangya hospital, Central South University, Changsha, Hunan 410008, China
    • ,
  • Yiyou Zou

      Affiliations

    • Department of Gastroenterology, Xiangya hospital, Central South University, Changsha, Hunan 410008, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 0731 4327106; fax: +86 0731 4327334.
    • ,
  • Jun Zhou

      Affiliations

    • Department of Surgery, Xiangya hospital, Central South University, Changsha, Hunan 410008, China
    • ,
  • Zhiming Wang

      Affiliations

    • Department of Surgery, Xiangya hospital, Central South University, Changsha, Hunan 410008, China
    • ,
  • Xiaoping Wan

      Affiliations

    • Department of Surgery, Xiangya hospital, Central South University, Changsha, Hunan 410008, China

,Accepted 30 March 2009.

References 

  1. Sasaki Eiji, Nagino Masato, Ebata Tomoki, Oda Koji, Arai T, Nishio H, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;1:99–105
  2. Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, et al. Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg. 2003;27:272–277
  3. Sai Katsutaka, Kajiwara Hirohisa. An immunohistochemical study of metaplastic endocrine cells in human gallbladder cancer. J Hepatobiliary Pancreat Surg. 2001;8:453–460
  4. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinoma of the gallbladder. Results of French Surgical Association. Surv Ann Surg. 1994;219:275–280
  5. Wang Binlin, Zhai Haiying, Chen Bingyi, Zhai SP, Yang HY, Chen XP, et al. Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2004;3:296–299
  6. Joseph Kelly F, Ryan Miller C, Buchsbaum Donald J, Gomez-Navarro Jesus, Barnes Mack N, Alvarez Ronald D, et al. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro. Clin Cancer Res. 2000;6:4323–4333
  7. Alvarez RD, Partridge EE, Khazaeli MB, Plott G, Austin M, Kilgore L, et al. Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study. Gynecol Oncol. 1997;65:94–101
  8. Meredith RF, Partridge EE, Alvarez RD, Khazaeli MB, Plott G, Russell CD, et al. Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49. J Nucl Med. 1996;37:1491–1496
  9. Japanese Society of Biliary Surgery . General rules for surgical and pathological studies on cancer of biliary tract. 5th ed.. Tokyo: Kanehara; 2003;
  10. In:  Sobin LH,  Wittekind C editor. International Union Against Cancer (UICC): TNM classification of malignant tumours. 6th ed.. New York: Wiley-Liss; 2002;
  11. Shi JS, Zhou LS, Han Y, Zhu AJ, Sun XJ, Yang YJ. Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int. 2004;3:448–452
  12. Hongyong XU, Li XU, Jianhong GAO, Kaizong LI. Detection of TAG-72 expression in human primary gallbladder carcinoma and its significance. Med J Shandong. 2007;3:16–18
  13. Takagawa Mayuko, Muguruma Naoki, Oguri Kaori, Imoto Yoshitaka, Okamoto Koichi, Kunio II, et al. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig Dis Sci. 2005;50:1410–1413
  14. Ito H, Matros E, Brooks DC, Osteen RT, Zinner MJ, Swanson RS, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg. 2004;8:183–190
  15. Pizzi C, Sgambato A, De Laurentiis M, Limite G, Panico L, Pettinato G, et al. TAG-72 expression and clinical outcome in primary breast cancer. Oncol Rep. 1999;6:1399–1403
  16. Castagna M, Nuti M, Squartini F. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast. Cancer Res. 1987;47:902–906
  17. Soomro S, Shousha S. Monoclonal antibody B72.3 in benign breast lesions. J Clin Pathol. 1990;43:1026–1028
  18. Contegiacomo A, Alimandi M, Muraro R, Pizzi C, Calderopoli R, De Marchis L, et al. Expression of epitopes of the tumour-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur J Cancer. 1994;6:813–820
  19. Chhieng DC, Rodriguez-Burford C, Talley LI, Sviglin H, Stockard CR, Kleinberg MJ, et al. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma. Hum Pathol. 2003;34:1016–1021
  20. Epivatianos A, Poulopoulos A, Kayavis I, Papanayotou P. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49. Oral Dis. 2000;6:112–117
  21. Galietta A, Pizzi C, Pettinato G, Limite G, Sgambato A, Lamberti M, et al. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype. Oncol Rep. 2002;9:135–140
  22. Karan D, Johansson SL, Lin MF, Batra SK. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Oncol Rep. 2000;8:1123–1126
  23. Peláez Buján Mdel C, Ruibal Morell A, Aza González J. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types. Rev Esp Enferm Dig. 1999;91:826–837
  24. Yoon SO, Lee TS, Kim SJ, Jang MH, Kang YJ, Park JH, et al. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J Biol Chem. 2006;281:6985–6992
  25. Chauhan SC, Vinayek N, Maher DM, Bell MC, Dunham KA, Koch MD, et al. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy. J Histochem Cytochem. 2007;55:867–875

PII: S0960-7404(09)00047-4

doi: 10.1016/j.suronc.2009.03.010

Surgical Oncology
Volume 19, Issue 2 , Pages 82-87 , June 2010

Article Tools

* Image Usage & Resolution